The reagent kit is used in the examination of patients diagnosed with non-small cell lung cancer (NSCLC) to determine indications for targeted therapy with EGFR tyrosine kinase inhibitors and monitor response to them.
The reagent kit is used in the examination of patients diagnosed with colorectal cancer to determine indications for targeted therapy.
The reagent kit is used in the examination of patients diagnosed with colorectal cancer to determine indications for targeted therapy.
The reagent kit is intended for non-invasive diagnostics of prostate cancer. The study determines the level of expression of the PCA3 gene, specific for prostate cancer, in relation to the level of the KLK3 gene, characteristic only for prostate tissue.
The reagent kit is intended for early non-invasive diagnosis of prostate cancer by detecting the chimeric TMPRSS2-ERG gene and determining the expression level of the PCA3 gene, specific for prostate cancer, in relation to the level of the KLK3 gene, characteristic only for prostate tissue.